Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis

被引:122
作者
Feghali-Bostwick, Carol A.
Tsai, Christopher G.
Valentine, Vincent G.
Kantrow, Stephen
Stoner, Michael W.
Pilewski, Joseph M.
Gadgil, Aneal
George, M. Patricia
Gibson, Kevin F.
Choi, Augustine M. K.
Kaminski, Naftali
Zhang, Yingze
Duncan, Steven R.
机构
[1] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Med, Ctr Interstitial Lung Dis, Pittsburgh, PA 15213 USA
[3] Ochsner Clin Fdn, Div Pulm Med, New Orleans, LA 70112 USA
关键词
D O I
10.4049/jimmunol.179.4.2592
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Idiopathic pulmonary fibrosis (IPF) is a morbid, refractory lung disorder with an unknown pathogenesis. To investigate potential adaptive immune mechanisms in IPF, we compared phenotypes and effector functions of peripheral CD4 T cells, autoantibody production, and proliferative responses of pulmonary hilar lymph node CD4 T cells to autologous lung extracts from afflicted patients and normals. Our results show that greater proportions of peripheral CD4 T lymphocytes in IPF subjects expressed MHC class II and CD154 (CD40L), and they more frequently elaborated TGF-beta 1, IL-10, and TNF-alpha. Abnormal CD4 T cell clonal expansions were found in all IPF patients, and 82 % of these subjects also had IgG autoantibodies against cellular Ags. IPF lung extracts stimulated proliferations of autologous CD4 T cells, unlike preparations from normals or those with other lung diseases, and the IPF proliferative responses were enhanced by repeated cycles of stimulation. Thus, CD4 T cells from IPF patients have characteristics typical of cell-mediated pathologic. responses, including augmented effector functions, provision of facultative help for autoantibody production, oligoclonal expansions, and proliferations driven by an Ag present in diseased tissues. Recognition that an autoreactive immune process is present in IPF can productively focus efforts toward identifying the responsible Ag, and implementing more effective therapies.
引用
收藏
页码:2592 / 2599
页数:8
相关论文
共 48 条
[1]  
Alaibac M, 2006, CLIN EXP RHEUMATOL, V24, pS14
[2]  
[Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
[3]  
Ask Kjetil, 2006, Proc Am Thorac Soc, V3, P389, DOI 10.1513/pats.200602-021TK
[4]   Synergy between CD40 Ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling [J].
Atamas, SP ;
Luzina, IG ;
Dai, HQ ;
Wilt, SG ;
White, B .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1139-1145
[5]  
Baughman R P, 2001, Curr Opin Pulm Med, V7, P309, DOI 10.1097/00063198-200109000-00010
[6]  
BRUIJN JA, 1994, J LAB CLIN MED, V123, P34
[7]   EXCESSIVE HELPER T-CELL FUNCTION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS - CORRELATION WITH DISEASE-ACTIVITY [J].
CATHCART, MK ;
EMDUR, LI ;
AHTIALASTEWART, K ;
AHMAD, M .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 43 (03) :382-394
[8]  
CHAPMAN JR, 1984, AM REV RESPIR DIS, V130, P439
[9]   Drug therapy in the management of type 1 autoimmune hepatitis [J].
Czaja, AJ .
DRUGS, 1999, 57 (01) :49-68
[10]   Monocyte chemoattractant protein 1 released from glycosaminoglycans mediates its profibrotic effects in systemic sclerosis via the release of interleukin-4 from T cells [J].
Distler, JHW ;
Jüngel, A ;
Caretto, D ;
Schulze-Horsel, U ;
Kowal-Bielecka, O ;
Gay, RE ;
Michel, BA ;
Müller-Ladner, U ;
Kalden, JR ;
Gay, S ;
Distler, O .
ARTHRITIS AND RHEUMATISM, 2006, 54 (01) :214-225